Bharat Immunologicals And Biologicals Corporation Limited - Company Profile

It is a pharma public limited union government company based in Uttar Pradesh, Uttar Pradesh, India, established in 1989.
1989 Uttar Pradesh, Uttar Pradesh, India Active
Last Updated:
Access Report
About Bharat Immunologicals And Biologicals Corporation Limited

Bharat Immunologicals And Biologicals Corporation Limited, a active public limited union government company, was established on 10 March 1989 in Uttar Pradesh, Uttar Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24232UP1989GOI010542. Registered under ROC Roc Uttar Pradesh Ii. it is listed on BSE: 524663. It has an authorized capital of ₹51.00 Cr and a paid-up capital of ₹43.18 Cr.

It upholds a compliant status. In 2022, it reported revenue of ₹79.49 Cr and a net worth of ₹105.35 Cr. Its leadership includes Alka Sharma (Director), Dhananjay Kumar Tiwary (Managing Director), Mohd Aslam (Director). Past directors included Sreeshan Raghalvan, Rajesh Kapur, Padmanaban Govindarajan. It holds ₹145.40 Cr open charges and ₹31.80 Cr settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Villaage Cholaps-Kotoali Dehat Bulandsahar, Uttar Pradesh, Uttar Pradesh, 203203.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L24232UP1989GOI010542

  • Registration Number

    010542

  • Incorporation Date

    10 March 1989

  • Authorized Capital

    ₹51.00 Cr

  • Paid-Up Capital

    ₹43.18 Cr

  • ROC Code

    Roc Uttar Pradesh Ii

  • Listing Status

    Listed (BSE: 524663)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 51.00 Cr
  • Paid Up Capital ₹ 43.18 Cr
  • Company Age 36 Year, 11 Months
  • Last Filing with ROC 31 Mar 2022
  • Open Charges ₹ 145.40 Cr
  • Satisfied Charges ₹ 31.80 Cr
  • Revenue Growth **** -8.65%
  • Profit Growth **** 51.67%
  • Ebitda **** 76.12%
  • Net Worth 209.49%
  • Total Assets **** 104.57%
Company report

Bharat Immunologicals And Biologicals Corporation Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Bharat Immunologicals And Biologicals Corporation Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Bharat Immunologicals And Biologicals Corporation Limited?
Current Directors
Name Designation Appointment Date Status
Alka Sharma Director 01 Nov 2016 Current
Dhananjay Kumar Tiwary Managing Director 18 Sep 2023 Current
Mohd Aslam Director 01 Nov 2016 Current
Madhu Dikshit Director 21 Jun 2019 Current
Pankaj Kumar Director 01 Feb 2022 Current
Yogendra Kumar Gupta Director 26 Oct 2010 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Managing Director 19 Aug 2015 Past
Pramod Abcsdd Managing Director 08 Aug 2011 Past
Pramod Abcsdd Director 16 Jan 2020 Past
Pramod Abcsdd Director 28 Oct 2021 Past
Pramod Abcsdd Managing Director 16 Sep 2022 Past
Pramod Abcsdd Director 09 Mar 2010 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Bharat Immunologicals And Biologicals Corporation.

Bharat Immunologicals And Biologicals Corporation Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 8.65% decrease. The company also saw a substantial improvement in profitability, with a 51.67% increase in profit. The company's net worth Soared by an impressive increase of 209.49%.

Bharat Immunologicals And Biologicals Corporation revenue growth over time
Bharat Immunologicals And Biologicals Corporation profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -8.65%
*******
*******
*******
*******
Revenue from Operations
*******
 -8.14%
*******
*******
*******
*******
Total Assets
*******
 104.57%
*******
*******
*******
*******
Profit or Loss
*******
 51.67%
*******
*******
*******
*******
Net Worth
*******
 209.49%
*******
*******
*******
*******
EBITDA
*******
 76.12%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Bharat Immunologicals And Biologicals Corporation?

In 2022, Bharat Immunologicals And Biologicals Corporation had a promoter holding of 59.25% and a public holding of 40.73%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,454,000,000.00

Satisfied Charges

₹318,000,000.00

Charges Breakdown by Lending Institutions
  • Canara Bank : 133.00 Cr
  • Industrial Development Bank Of India : 10.10 Cr
  • Industrial Credit & Investment Corporation Of India Ltd. : 0.95 Cr
  • The State Bank Of India : 0.80 Cr
  • State Bank Of Hyderabad : 0.55 Cr
Latest Charge Details
Date Lender Amount Status
10 Feb 2012 Canara Bank ₹133.00 Cr Open
26 May 1993 Industrial Credit & Investment Corporation Of India Ltd. ₹9.50 M Open
17 Sep 1992 The State Bank Of India ₹8.00 M Open
24 Mar 1992 State Bank Of Hyderabad ₹5.50 M Open
03 May 1991 Industrial Development Bank Of India ₹7.50 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Bharat Immunologicals And Biologicals Corporation?

Unlock and access historical data on people associated with Bharat Immunologicals And Biologicals Corporation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Bharat Immunologicals And Biologicals Corporation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bharat Immunologicals And Biologicals Corporation's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Bharat Immunologicals And Biologicals Corporation
Recent Activity within the Organization
  • Director Appointment

    Dhananjay Kumar Tiwary was appointed as a Managing Director was appointed as a Managing Director on 18 Sep 2023 & has been associated with this company since 2 years 5 months . was recorded as a recent event.

  • Annual General Meeting

    Progress on Bharat Immunologicals And Biologicals Corporation Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Bharat Immunologicals And Biologicals Corporation Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Uttar Pradesh Ii. was documented.

  • Director Appointment

    Pankaj Kumar was appointed as a Director was appointed as a Director on 01 Feb 2022 & has been associated with this company since 4 years 28 days . was recorded as a recent event.

  • Charges

    A charge registered on 28 Aug 2004 via Charge ID 90272867 with Canara Bank was fully satisfied on 15 Sep 2021. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 31 Oct 1998 via Charge ID 90272130 with Canara Bank was fully satisfied on 15 Sep 2021. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Bharat Immunologicals And Biologicals Corporation Limited?

The CIN of Bharat Immunologicals And Biologicals Corporation Limited is L24232UP1989GOI010542.

Where is Bharat Immunologicals And Biologicals Corporation Limited headquartered?

Bharat Immunologicals And Biologicals Corporation Limited is headquartered at Villaage Cholaps-Kotoali Dehat Bulandsahar, Uttar Pradesh, Uttar Pradesh, 203203.

When was Bharat Immunologicals And Biologicals Corporation Limited incorporated?

Bharat Immunologicals And Biologicals Corporation Limited was incorporated on 10 March 1989.

Who are the current directors of Bharat Immunologicals And Biologicals Corporation Limited?

The current directors of Bharat Immunologicals And Biologicals Corporation Limited are

What is the primary industry of Bharat Immunologicals And Biologicals Corporation Limited?

The primary industry of Bharat Immunologicals And Biologicals Corporation Limited is Manufacturing.

Is Bharat Immunologicals And Biologicals Corporation Limited a listed company?

Bharat Immunologicals And Biologicals Corporation Limited is listed. It is listed on BSE: 524663.

What is the capital structure of Bharat Immunologicals And Biologicals Corporation Limited?

The authorized capital of Bharat Immunologicals And Biologicals Corporation Limited is ₹51.00 Cr, and the paid-up capital is ₹43.18 Cr.

What is the compliance status of Bharat Immunologicals And Biologicals Corporation Limited?

The compliance status of Bharat Immunologicals And Biologicals Corporation Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available